The priority review process in Canada—I think it's called fast-tracking in the United States, but ours is priority review—doesn't change the standards. Those standards are the same whether a drug is fast-tracked or not. What it does is it responds to a concern that was voiced by Canadians who were very ill when the HIV and AIDS crisis started. That was to find a way to provide medications to them more quickly. They voiced very clearly that they were willing to accept more risk for that. The standards are exactly the same.
On October 18th, 2012. See this statement in context.